Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin

Identifieur interne : 000960 ( Pmc/Corpus ); précédent : 000959; suivant : 000961

A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin

Auteurs : Anna Carbone ; Virginia Span ; Barbara Parrino ; Cristina Ciancimino ; Orazio A. Attanasi ; Gianfranco Favi

Source :

RBID : PMC:6269752

Abstract

A series of substituted ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1H-indol-3-yl)-4-[(1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylates were prepared in excellent yields (82-98%) by one-pot reactions between β-dicarbonyl compounds 12ae and 1,2-diaza-1,3-diene (DD) 13. Derivatives 10a,ce, deazaanalogues of the bis-indole alkaloid topsentin, screened by the National Cancer Institute (Bethesda, MD, USA) in the in vitro one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity, with the exception of compound 9e, which showed moderate activity against the HOP-92 cell line of the non small cell lung cancer sub-panel and the SNB-75 cell line of the CNS sub-panel.


Url:
DOI: 10.3390/molecules18032518
PubMed: 23442928
PubMed Central: 6269752

Links to Exploration step

PMC:6269752

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin</title>
<author>
<name sortKey="Carbone, Anna" sort="Carbone, Anna" uniqKey="Carbone A" first="Anna" last="Carbone">Anna Carbone</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Span, Virginia" sort="Span, Virginia" uniqKey="Span V" first="Virginia" last="Span">Virginia Span</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Parrino, Barbara" sort="Parrino, Barbara" uniqKey="Parrino B" first="Barbara" last="Parrino">Barbara Parrino</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ciancimino, Cristina" sort="Ciancimino, Cristina" uniqKey="Ciancimino C" first="Cristina" last="Ciancimino">Cristina Ciancimino</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Attanasi, Orazio A" sort="Attanasi, Orazio A" uniqKey="Attanasi O" first="Orazio A." last="Attanasi">Orazio A. Attanasi</name>
<affiliation>
<nlm:aff id="af2-molecules-18-02518">Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Via I Maggetti 24, 61029 Urbino, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Favi, Gianfranco" sort="Favi, Gianfranco" uniqKey="Favi G" first="Gianfranco" last="Favi">Gianfranco Favi</name>
<affiliation>
<nlm:aff id="af2-molecules-18-02518">Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Via I Maggetti 24, 61029 Urbino, Italy</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23442928</idno>
<idno type="pmc">6269752</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269752</idno>
<idno type="RBID">PMC:6269752</idno>
<idno type="doi">10.3390/molecules18032518</idno>
<date when="2013">2013</date>
<idno type="wicri:Area/Pmc/Corpus">000960</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000960</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin</title>
<author>
<name sortKey="Carbone, Anna" sort="Carbone, Anna" uniqKey="Carbone A" first="Anna" last="Carbone">Anna Carbone</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Span, Virginia" sort="Span, Virginia" uniqKey="Span V" first="Virginia" last="Span">Virginia Span</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Parrino, Barbara" sort="Parrino, Barbara" uniqKey="Parrino B" first="Barbara" last="Parrino">Barbara Parrino</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Ciancimino, Cristina" sort="Ciancimino, Cristina" uniqKey="Ciancimino C" first="Cristina" last="Ciancimino">Cristina Ciancimino</name>
<affiliation>
<nlm:aff id="af1-molecules-18-02518">Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Attanasi, Orazio A" sort="Attanasi, Orazio A" uniqKey="Attanasi O" first="Orazio A." last="Attanasi">Orazio A. Attanasi</name>
<affiliation>
<nlm:aff id="af2-molecules-18-02518">Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Via I Maggetti 24, 61029 Urbino, Italy</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Favi, Gianfranco" sort="Favi, Gianfranco" uniqKey="Favi G" first="Gianfranco" last="Favi">Gianfranco Favi</name>
<affiliation>
<nlm:aff id="af2-molecules-18-02518">Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Via I Maggetti 24, 61029 Urbino, Italy</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Molecules</title>
<idno type="eISSN">1420-3049</idno>
<imprint>
<date when="2013">2013</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>A series of substituted ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxylates were prepared in excellent yields (82-98%) by one-pot reactions between β-dicarbonyl compounds
<bold>12a</bold>
<bold>e</bold>
and 1,2-diaza-1,3-diene (DD)
<bold>13</bold>
. Derivatives
<bold>10a</bold>
,
<bold>c</bold>
<bold>e</bold>
, deazaanalogues of the bis-indole alkaloid topsentin, screened by the National Cancer Institute (Bethesda, MD, USA) in the
<italic>in vitro</italic>
one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity, with the exception of compound
<bold>9e</bold>
, which showed moderate activity against the HOP-92 cell line of the non small cell lung cancer sub-panel and the SNB-75 cell line of the CNS sub-panel.</p>
</div>
</front>
<back>
<div1 type="bibliography">
<listBibl>
<biblStruct>
<analytic>
<author>
<name sortKey="Shin, J" uniqKey="Shin J">J. Shin</name>
</author>
<author>
<name sortKey="Seo, Y" uniqKey="Seo Y">Y. Seo</name>
</author>
<author>
<name sortKey="Cho, K W" uniqKey="Cho K">K.W. Cho</name>
</author>
<author>
<name sortKey="Rho, J R" uniqKey="Rho J">J.R. Rho</name>
</author>
<author>
<name sortKey="Sim, C" uniqKey="Sim C">C. Sim</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Casapullo, A" uniqKey="Casapullo A">A. Casapullo</name>
</author>
<author>
<name sortKey="Bifulco, G" uniqKey="Bifulco G">G. Bifulco</name>
</author>
<author>
<name sortKey="Bruno, I" uniqKey="Bruno I">I. Bruno</name>
</author>
<author>
<name sortKey="Riccio, R" uniqKey="Riccio R">R. Riccio</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bao, B" uniqKey="Bao B">B. Bao</name>
</author>
<author>
<name sortKey="Sun, Q" uniqKey="Sun Q">Q. Sun</name>
</author>
<author>
<name sortKey="Yao, X" uniqKey="Yao X">X. Yao</name>
</author>
<author>
<name sortKey="Hong, J" uniqKey="Hong J">J. Hong</name>
</author>
<author>
<name sortKey="Lee, C" uniqKey="Lee C">C. Lee</name>
</author>
<author>
<name sortKey="Sim, C J" uniqKey="Sim C">C.J. Sim</name>
</author>
<author>
<name sortKey="Jung, J H" uniqKey="Jung J">J.H. Jung</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gul, W" uniqKey="Gul W">W. Gul</name>
</author>
<author>
<name sortKey="Hamann, M T" uniqKey="Hamann M">M.T. Hamann</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Kohmoto, S" uniqKey="Kohmoto S">S. Kohmoto</name>
</author>
<author>
<name sortKey="Kashman, Y" uniqKey="Kashman Y">Y. Kashman</name>
</author>
<author>
<name sortKey="Mcconnell, O J" uniqKey="Mcconnell O">O.J. McConnell</name>
</author>
<author>
<name sortKey="Rinehart, K L" uniqKey="Rinehart K">K.L. Rinehart</name>
</author>
<author>
<name sortKey="Wright, A" uniqKey="Wright A">A. Wright</name>
</author>
<author>
<name sortKey="Koehn, F" uniqKey="Koehn F">F. Koehn</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Morris, S A" uniqKey="Morris S">S.A. Morris</name>
</author>
<author>
<name sortKey="Andersen, R J" uniqKey="Andersen R">R.J. Andersen</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Fahy, E" uniqKey="Fahy E">E. Fahy</name>
</author>
<author>
<name sortKey="Potts, B C M" uniqKey="Potts B">B.C.M. Potts</name>
</author>
<author>
<name sortKey="Faulkner, D J" uniqKey="Faulkner D">D.J. Faulkner</name>
</author>
<author>
<name sortKey="Smith, K" uniqKey="Smith K">K. Smith</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Wright, A E" uniqKey="Wright A">A.E. Wright</name>
</author>
<author>
<name sortKey="Pomponi, S A" uniqKey="Pomponi S">S.A. Pomponi</name>
</author>
<author>
<name sortKey="Cross, S S" uniqKey="Cross S">S.S. Cross</name>
</author>
<author>
<name sortKey="Mccarthy, P" uniqKey="Mccarthy P">P. McCarthy</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Capon, R J" uniqKey="Capon R">R.J. Capon</name>
</author>
<author>
<name sortKey="Rooney, F" uniqKey="Rooney F">F. Rooney</name>
</author>
<author>
<name sortKey="Murray, L M" uniqKey="Murray L">L.M. Murray</name>
</author>
<author>
<name sortKey="Collins, E" uniqKey="Collins E">E. Collins</name>
</author>
<author>
<name sortKey="Sim, A T R" uniqKey="Sim A">A.T.R. Sim</name>
</author>
<author>
<name sortKey="Rostas, J A P" uniqKey="Rostas J">J.A.P. Rostas</name>
</author>
<author>
<name sortKey="Butler, M S" uniqKey="Butler M">M.S. Butler</name>
</author>
<author>
<name sortKey="Carroll, A R" uniqKey="Carroll A">A.R. Carroll</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Alvarez, M" uniqKey="Alvarez M">M. Alvarez</name>
</author>
<author>
<name sortKey="Salas, M" uniqKey="Salas M">M. Salas</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sakem, S" uniqKey="Sakem S">S. Sakem</name>
</author>
<author>
<name sortKey="Sun, H H" uniqKey="Sun H">H.H. Sun</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Bartik, K" uniqKey="Bartik K">K. Bartik</name>
</author>
<author>
<name sortKey="Braekman, J C" uniqKey="Braekman J">J.-C. Braekman</name>
</author>
<author>
<name sortKey="Daloze, D" uniqKey="Daloze D">D. Daloze</name>
</author>
<author>
<name sortKey="Stoller, C" uniqKey="Stoller C">C. Stoller</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Burres, N S" uniqKey="Burres N">N.S. Burres</name>
</author>
<author>
<name sortKey="Barber, D A" uniqKey="Barber D">D.A. Barber</name>
</author>
<author>
<name sortKey="Gunasekera, S P" uniqKey="Gunasekera S">S.P. Gunasekera</name>
</author>
<author>
<name sortKey="Shen, L L" uniqKey="Shen L">L.L. Shen</name>
</author>
<author>
<name sortKey="Clement, J" uniqKey="Clement J">J. Clement</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Tsuji, S" uniqKey="Tsuji S">S. Tsuji</name>
</author>
<author>
<name sortKey="Rinehart, K L" uniqKey="Rinehart K">K.L. Rinehart</name>
</author>
<author>
<name sortKey="Gunasekera, S P" uniqKey="Gunasekera S">S.P. Gunasekera</name>
</author>
<author>
<name sortKey="Kashman, Y" uniqKey="Kashman Y">Y. Kashman</name>
</author>
<author>
<name sortKey="Cross, S S" uniqKey="Cross S">S.S. Cross</name>
</author>
<author>
<name sortKey="Lui, M S" uniqKey="Lui M">M.S. Lui</name>
</author>
<author>
<name sortKey="Pomponi, S A" uniqKey="Pomponi S">S.A. Pomponi</name>
</author>
<author>
<name sortKey="Diaz, M C" uniqKey="Diaz M">M.C. Diaz</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Gu, X" uniqKey="Gu X">X. Gu</name>
</author>
<author>
<name sortKey="Wan, X" uniqKey="Wan X">X. Wan</name>
</author>
<author>
<name sortKey="Jiang, B" uniqKey="Jiang B">B. Jiang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jiang, B" uniqKey="Jiang B">B. Jiang</name>
</author>
<author>
<name sortKey="Gu, X H" uniqKey="Gu X">X.H. Gu</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jiang, B" uniqKey="Jiang B">B. Jiang</name>
</author>
<author>
<name sortKey="Xiong, X" uniqKey="Xiong X">X. Xiong</name>
</author>
<author>
<name sortKey="Yang, C" uniqKey="Yang C">C. Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Jiang, B" uniqKey="Jiang B">B. Jiang</name>
</author>
<author>
<name sortKey="Xiong, X" uniqKey="Xiong X">X. Xiong</name>
</author>
<author>
<name sortKey="Yang, C" uniqKey="Yang C">C. Yang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Xiong, W" uniqKey="Xiong W">W. Xiong</name>
</author>
<author>
<name sortKey="Yang, C" uniqKey="Yang C">C. Yang</name>
</author>
<author>
<name sortKey="Jiang, B" uniqKey="Jiang B">B. Jiang</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Diana, P" uniqKey="Diana P">P. Diana</name>
</author>
<author>
<name sortKey="Carbone, A" uniqKey="Carbone A">A. Carbone</name>
</author>
<author>
<name sortKey="Barraja, P" uniqKey="Barraja P">P. Barraja</name>
</author>
<author>
<name sortKey="Montalbano, A" uniqKey="Montalbano A">A. Montalbano</name>
</author>
<author>
<name sortKey="Martorana, A" uniqKey="Martorana A">A. Martorana</name>
</author>
<author>
<name sortKey="Dattolo, G" uniqKey="Dattolo G">G. Dattolo</name>
</author>
<author>
<name sortKey="Gia, O" uniqKey="Gia O">O. Gia</name>
</author>
<author>
<name sortKey="Dalla Via, L" uniqKey="Dalla Via L">L. Dalla Via</name>
</author>
<author>
<name sortKey="Cirrincione, G" uniqKey="Cirrincione G">G. Cirrincione</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Diana, P" uniqKey="Diana P">P. Diana</name>
</author>
<author>
<name sortKey="Carbone, A" uniqKey="Carbone A">A. Carbone</name>
</author>
<author>
<name sortKey="Barraja, P" uniqKey="Barraja P">P. Barraja</name>
</author>
<author>
<name sortKey="Martorana, A" uniqKey="Martorana A">A. Martorana</name>
</author>
<author>
<name sortKey="Gia, O" uniqKey="Gia O">O. Gia</name>
</author>
<author>
<name sortKey="Dalla Via, L" uniqKey="Dalla Via L">L. Dalla Via</name>
</author>
<author>
<name sortKey="Cirrincione, G" uniqKey="Cirrincione G">G. Cirrincione</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Diana, P" uniqKey="Diana P">P. Diana</name>
</author>
<author>
<name sortKey="Carbone, A" uniqKey="Carbone A">A. Carbone</name>
</author>
<author>
<name sortKey="Barraja, P" uniqKey="Barraja P">P. Barraja</name>
</author>
<author>
<name sortKey="Kelter, H H" uniqKey="Kelter H">H.H. Kelter</name>
</author>
<author>
<name sortKey="Fiebig, G" uniqKey="Fiebig G">G. Fiebig</name>
</author>
<author>
<name sortKey="Cirrincione, G" uniqKey="Cirrincione G">G. Cirrincione</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Carbone, A" uniqKey="Carbone A">A. Carbone</name>
</author>
<author>
<name sortKey="Parrino, B" uniqKey="Parrino B">B. Parrino</name>
</author>
<author>
<name sortKey="Barraja, P" uniqKey="Barraja P">P. Barraja</name>
</author>
<author>
<name sortKey="Span, V" uniqKey="Span V">V. Spanò</name>
</author>
<author>
<name sortKey="Cirrincione, G" uniqKey="Cirrincione G">G. Cirrincione</name>
</author>
<author>
<name sortKey="Diana, P" uniqKey="Diana P">P. Diana</name>
</author>
<author>
<name sortKey="Maier, A" uniqKey="Maier A">A. Maier</name>
</author>
<author>
<name sortKey="Kelter, G" uniqKey="Kelter G">G. Kelter</name>
</author>
<author>
<name sortKey="Fiebig, H H" uniqKey="Fiebig H">H-H. Fiebig</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Attanasi, O A" uniqKey="Attanasi O">O.A. Attanasi</name>
</author>
<author>
<name sortKey="De Crescentini, L" uniqKey="De Crescentini L">L. De Crescentini</name>
</author>
<author>
<name sortKey="Favi, G" uniqKey="Favi G">G. Favi</name>
</author>
<author>
<name sortKey="Filippone, P" uniqKey="Filippone P">P. Filippone</name>
</author>
<author>
<name sortKey="Mantellini, F" uniqKey="Mantellini F">F. Mantellini</name>
</author>
<author>
<name sortKey="Perrulli, F R" uniqKey="Perrulli F">F.R. Perrulli</name>
</author>
<author>
<name sortKey="Santeusanio, S" uniqKey="Santeusanio S">S. Santeusanio</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Attanasi, O A" uniqKey="Attanasi O">O.A. Attanasi</name>
</author>
<author>
<name sortKey="Grossi, M" uniqKey="Grossi M">M. Grossi</name>
</author>
<author>
<name sortKey="Serra Zanetti, F" uniqKey="Serra Zanetti F">F. Serra-Zanetti</name>
</author>
<author>
<name sortKey="Foresti, E" uniqKey="Foresti E">E. Foresti</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Monks, A" uniqKey="Monks A">A. Monks</name>
</author>
<author>
<name sortKey="Scudiero, D" uniqKey="Scudiero D">D. Scudiero</name>
</author>
<author>
<name sortKey="Skehan, P" uniqKey="Skehan P">P. Skehan</name>
</author>
<author>
<name sortKey="Shoemaker, R" uniqKey="Shoemaker R">R. Shoemaker</name>
</author>
<author>
<name sortKey="Paull, K" uniqKey="Paull K">K. Paull</name>
</author>
<author>
<name sortKey="Vistica, D" uniqKey="Vistica D">D. Vistica</name>
</author>
<author>
<name sortKey="Hose, C" uniqKey="Hose C">C. Hose</name>
</author>
<author>
<name sortKey="Langely, J" uniqKey="Langely J">J. Langely</name>
</author>
<author>
<name sortKey="Cronise, P" uniqKey="Cronise P">P. Cronise</name>
</author>
<author>
<name sortKey="Vaigro Wolff, A" uniqKey="Vaigro Wolff A">A. Vaigro-Wolff</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Sommer, S" uniqKey="Sommer S">S. Sommer</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Attanasi, O A" uniqKey="Attanasi O">O.A. Attanasi</name>
</author>
<author>
<name sortKey="Filippone, P" uniqKey="Filippone P">P. Filippone</name>
</author>
<author>
<name sortKey="Mei, A" uniqKey="Mei A">A. Mei</name>
</author>
<author>
<name sortKey="Santeusanio, S" uniqKey="Santeusanio S">S. Santeusanio</name>
</author>
</analytic>
</biblStruct>
<biblStruct>
<analytic>
<author>
<name sortKey="Attanasi, O A" uniqKey="Attanasi O">O.A. Attanasi</name>
</author>
<author>
<name sortKey="Filippone, P" uniqKey="Filippone P">P. Filippone</name>
</author>
<author>
<name sortKey="Mei, A" uniqKey="Mei A">A. Mei</name>
</author>
<author>
<name sortKey="Santeusanio, S" uniqKey="Santeusanio S">S. Santeusanio</name>
</author>
</analytic>
</biblStruct>
<biblStruct></biblStruct>
</listBibl>
</div1>
</back>
</TEI>
<pmc article-type="research-article">
<pmc-dir>properties open_access</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecules</journal-id>
<journal-id journal-id-type="iso-abbrev">Molecules</journal-id>
<journal-id journal-id-type="publisher-id">molecules</journal-id>
<journal-title-group>
<journal-title>Molecules</journal-title>
</journal-title-group>
<issn pub-type="epub">1420-3049</issn>
<publisher>
<publisher-name>MDPI</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">23442928</article-id>
<article-id pub-id-type="pmc">6269752</article-id>
<article-id pub-id-type="doi">10.3390/molecules18032518</article-id>
<article-id pub-id-type="publisher-id">molecules-18-02518</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Carbone</surname>
<given-names>Anna</given-names>
</name>
<xref ref-type="aff" rid="af1-molecules-18-02518">1</xref>
<xref rid="c1-molecules-18-02518" ref-type="corresp">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Spanò</surname>
<given-names>Virginia</given-names>
</name>
<xref ref-type="aff" rid="af1-molecules-18-02518">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parrino</surname>
<given-names>Barbara</given-names>
</name>
<xref ref-type="aff" rid="af1-molecules-18-02518">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ciancimino</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="af1-molecules-18-02518">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Attanasi</surname>
<given-names>Orazio A.</given-names>
</name>
<xref ref-type="aff" rid="af2-molecules-18-02518">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Favi</surname>
<given-names>Gianfranco</given-names>
</name>
<xref ref-type="aff" rid="af2-molecules-18-02518">2</xref>
<xref rid="c1-molecules-18-02518" ref-type="corresp">*</xref>
</contrib>
</contrib-group>
<aff id="af1-molecules-18-02518">
<label>1</label>
Dipartimento di Scienze e Tecnologie Biologiche Chimiche e Farmaceutiche, Università degli Studi di Palermo, Via Archirafi 32, 90123 Palermo, Italy</aff>
<aff id="af2-molecules-18-02518">
<label>2</label>
Dipartimento di Scienze Biomolecolari, Università degli Studi di Urbino “Carlo Bo”, Via I Maggetti 24, 61029 Urbino, Italy</aff>
<author-notes>
<corresp id="c1-molecules-18-02518">
<label>*</label>
Authors to whom correspondence should be addressed; E-Mails:
<email>anna.carbone@unipa.it</email>
(A.C.);
<email>gianfranco.favi@uniurb.it</email>
(G.F.); Tel.: +39-091-23896826 (A.C.); Fax: +39-091-23860854 (A.C.); Tel.: +39-0722-303440 (G.F.).</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>26</day>
<month>2</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="collection">
<month>3</month>
<year>2013</year>
</pub-date>
<volume>18</volume>
<issue>3</issue>
<fpage>2518</fpage>
<lpage>2527</lpage>
<history>
<date date-type="received">
<day>21</day>
<month>1</month>
<year>2013</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>1</month>
<year>2013</year>
</date>
<date date-type="accepted">
<day>07</day>
<month>2</month>
<year>2013</year>
</date>
</history>
<permissions>
<copyright-statement>© 2013 by the authors; licensee MDPI, Basel, Switzerland.</copyright-statement>
<copyright-year>2013</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/">
<license-p>
<pmc-comment>CREATIVE COMMONS</pmc-comment>
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>
).</license-p>
</license>
</permissions>
<abstract>
<p>A series of substituted ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxylates were prepared in excellent yields (82-98%) by one-pot reactions between β-dicarbonyl compounds
<bold>12a</bold>
<bold>e</bold>
and 1,2-diaza-1,3-diene (DD)
<bold>13</bold>
. Derivatives
<bold>10a</bold>
,
<bold>c</bold>
<bold>e</bold>
, deazaanalogues of the bis-indole alkaloid topsentin, screened by the National Cancer Institute (Bethesda, MD, USA) in the
<italic>in vitro</italic>
one dose primary anticancer assay against a panel of about 60 human tumor cell lines, showed no significant activity, with the exception of compound
<bold>9e</bold>
, which showed moderate activity against the HOP-92 cell line of the non small cell lung cancer sub-panel and the SNB-75 cell line of the CNS sub-panel.</p>
</abstract>
<kwd-group>
<kwd>topsentin</kwd>
<kwd>bis-indole alkaloids</kwd>
<kwd>antitumor activity</kwd>
<kwd>ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)-carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxylates</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec>
<title>1. Introduction</title>
<p>Marine invertebrates represent a very important source of bioactive molecules. In particular, bis-indole alkaloids (
<xref ref-type="fig" rid="molecules-18-02518-f001">Figure 1</xref>
), characterized by two indole units bound to a spacer through their 3 position, constitute a class of deep-sea sponge metabolites with potent antiinflammatory, antimicrobial, antiviral and antitumor biological activity [
<xref rid="B1-molecules-18-02518" ref-type="bibr">1</xref>
,
<xref rid="B2-molecules-18-02518" ref-type="bibr">2</xref>
,
<xref rid="B3-molecules-18-02518" ref-type="bibr">3</xref>
,
<xref rid="B4-molecules-18-02518" ref-type="bibr">4</xref>
]. The first isolated four dragmacidins
<bold>1</bold>
, containing the six membered piperazine heterocyclic ring, were isolated from a large number of deep water sponges including
<italic>Dragmacidon</italic>
,
<italic>Halicortex</italic>
,
<italic>Spongosorites</italic>
,
<italic>Hexadella</italic>
and the tunicate
<italic>Didemnum candidum</italic>
and showed, among other biological properties, modest cytotoxic activity [
<xref rid="B5-molecules-18-02518" ref-type="bibr">5</xref>
,
<xref rid="B6-molecules-18-02518" ref-type="bibr">6</xref>
,
<xref rid="B7-molecules-18-02518" ref-type="bibr">7</xref>
]. Successively, more complex components of this family such as dragmacidin D (
<bold>2</bold>
), having a pyrazinone moiety as a spacer, exhibited varied biological properties such as inhibition of serine-threonine protein phosphatases, antiviral, antimicrobial and anticancer activities [
<xref rid="B8-molecules-18-02518" ref-type="bibr">8</xref>
,
<xref rid="B9-molecules-18-02518" ref-type="bibr">9</xref>
]. Nortopsentins A–C
<bold>3</bold>
, with imidazole as a five membered ring spacer, were isolated from the marine sponge
<italic>Spongosorites ruetzleri</italic>
and showed
<italic>in vitro</italic>
cytotoxicity against P388 cells and antifungal activity against
<italic>Candida albicans</italic>
[
<xref rid="B10-molecules-18-02518" ref-type="bibr">10</xref>
,
<xref rid="B11-molecules-18-02518" ref-type="bibr">11</xref>
]. Topsentins
<bold>4</bold>
[
<xref rid="B12-molecules-18-02518" ref-type="bibr">12</xref>
], having a bis(indolyl)imidazole skeleton (
<xref ref-type="fig" rid="molecules-18-02518-f001">Figure 1</xref>
), exhibited antiviral and antitumor activity. In particular compounds
<bold>4a</bold>
and
<bold>4b</bold>
had
<italic>in vitro</italic>
activity against HSV-1, vesicular stomatitis virus (VSV), and corona virus A-59 [
<xref rid="B13-molecules-18-02518" ref-type="bibr">13</xref>
]. Topsentin
<bold>4a</bold>
showed
<italic>in vitro</italic>
cytotoxicity against P388 murine tumor cells (IC
<sub>50</sub>
3.0 µg/mL) and human tumor cells (HCT-8, A-549, T47D 20 µg/mL) and
<italic>in vivo</italic>
activity against P388 (T/C 137%, 150 mg/kg) and B16 melanoma (T/C 144%, 37.5 mg/kg) [
<xref rid="B14-molecules-18-02518" ref-type="bibr">14</xref>
]. Compounds
<bold>4b</bold>
and
<bold>4c</bold>
exhibited antiproliferative activity against human broncopulmonary cancer cells (NSCLC-N6) with IC
<sub>50</sub>
values of 12.0 and 6.3 µg/mL, respectively [
<xref rid="B2-molecules-18-02518" ref-type="bibr">2</xref>
]. Due to these interesting biological activities, there has been a rapid growth of interest in the synthesis of this class of compounds and their analogues [
<xref rid="B15-molecules-18-02518" ref-type="bibr">15</xref>
,
<xref rid="B16-molecules-18-02518" ref-type="bibr">16</xref>
,
<xref rid="B17-molecules-18-02518" ref-type="bibr">17</xref>
,
<xref rid="B18-molecules-18-02518" ref-type="bibr">18</xref>
,
<xref rid="B19-molecules-18-02518" ref-type="bibr">19</xref>
].</p>
<p>We have recently reported the synthesis and the antitumor activity of bis-indolyl thiophene [
<xref rid="B20-molecules-18-02518" ref-type="bibr">20</xref>
]
<bold>5</bold>
, pyrazoles [
<xref rid="B21-molecules-18-02518" ref-type="bibr">21</xref>
]
<bold>6</bold>
, furans [
<xref rid="B22-molecules-18-02518" ref-type="bibr">22</xref>
]
<bold>7</bold>
and isoxazoles [
<xref rid="B22-molecules-18-02518" ref-type="bibr">22</xref>
]
<bold>8</bold>
(
<xref ref-type="fig" rid="molecules-18-02518-f001">Figure 1</xref>
) that showed inhibitory activity against a wide range of human tumor cell lines, generally in the micro- and submicromolar range. Even more recently bis-indolyl pyrroles [
<xref rid="B23-molecules-18-02518" ref-type="bibr">23</xref>
]
<bold>9</bold>
have exhibited concentration-dependent antitumor activity towards a panel of 42 human tumor cell lines, with mean IC
<sub>50</sub>
values of 1.54 µM and 0.67 µM, respectively. Moreover, investigating human tumor xenografts in an
<italic>ex vivo</italic>
clonogenic assay revealed selective antitumor activity.</p>
<p>Thus, in our effort to search for novel antitumor compounds, and with the aim to develop more potent and selective agents and considering the good antiproliferative activity of bis-indolyl pyrroles, we designed further new analogues of the indole alkaloid topsentin. We report herein a synthesis of ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxylates derivatives
<bold>10a</bold>
<bold>e</bold>
(
<xref ref-type="fig" rid="molecules-18-02518-f001">Figure 1</xref>
), in which the imidazole unit moiety of topsentin was replaced by a highly functionalized pyrrole ring and the two indolyl portions are placed in adjacent positions.</p>
<fig id="molecules-18-02518-f001" position="float">
<label>Figure 1</label>
<caption>
<p>Bis-indolyl alkaloids.</p>
</caption>
<graphic xlink:href="molecules-18-02518-g001"></graphic>
</fig>
</sec>
<sec>
<title>2. Results and Discussion</title>
<p>The key intermediates for the synthesis of ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxylates
<bold>10a</bold>
<bold>e</bold>
are the β-diketones
<bold>12a</bold>
<bold>e</bold>
prepared in good yields (45–70%) from
<italic>N</italic>
-methylindoles
<bold>11a</bold>
<bold>e</bold>
by a Friedel-Crafts reaction using malonyl dichloride in dichloromethane, as previously reported [
<xref rid="B22-molecules-18-02518" ref-type="bibr">22</xref>
] (
<xref ref-type="scheme" rid="molecules-18-02518-f002">Scheme 1</xref>
).</p>
<fig id="molecules-18-02518-f002" position="float">
<object-id pub-id-type="pii">molecules-18-02518-f002_Scheme 1</object-id>
<label>Scheme 1</label>
<caption>
<p>Synthesis of derivatives
<bold>10a</bold>
<bold>e</bold>
.</p>
</caption>
<graphic xlink:href="molecules-18-02518-g002"></graphic>
</fig>
<p>One-pot reaction of the latter with 1,2-diaza-1,3-diene (DD)
<bold>13</bold>
in tetrahydrofuran and in the presence of CuCl
<sub>2</sub>
∙2H
<sub>2</sub>
O as catalyst furnished the corresponding ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxyl-ates
<bold>10a</bold>
<bold>e</bold>
in excellent yields (82–98%).</p>
<p>The mechanism of the latter reaction involves the copper-promoted attack of the active carbon atom of diketones
<bold>12a</bold>
<bold>e</bold>
at the terminal carbon of the heterodiene system of DD (
<bold>13</bold>
) to give an adduct intermediate
<bold>A</bold>
, followed by an intramolecular cyclization reaction to generate the ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-5-hydroxy-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-4,5-dihydro-1
<italic>H</italic>
-pyrrole-3-carboxylate derivative
<bold>B</bold>
. Then, the spontaneous loss of a water molecule provides the related aromatic pyrrole (
<xref ref-type="scheme" rid="molecules-18-02518-f003">Scheme 2</xref>
). This five membered ring closure is substantiated by several papers previous presented by some of us [
<xref rid="B24-molecules-18-02518" ref-type="bibr">24</xref>
,
<xref rid="B25-molecules-18-02518" ref-type="bibr">25</xref>
].</p>
<fig id="molecules-18-02518-f003" position="float">
<object-id pub-id-type="pii">molecules-18-02518-f003_Scheme 2</object-id>
<label>Scheme 2</label>
<caption>
<p>Mechanism.</p>
</caption>
<graphic xlink:href="molecules-18-02518-g003"></graphic>
</fig>
<p>Four pyrrole derivatives
<bold>10a</bold>
,
<bold>c</bold>
<bold>e</bold>
were selected for a single dose concentration,
<italic>in vitro</italic>
disease-oriented antitumor screenings against the full NCI panel of about 60 human tumor cell lines that have grouped in disease sub-panels including leukaemia, non-small lung, colon, central nervous system, melanoma, ovarian, renal, prostate, and breast tumors cell lines [
<xref rid="B26-molecules-18-02518" ref-type="bibr">26</xref>
]. The results obtained take into consideration the percent growth of the treated cells. The results revealed that compound
<bold>10e</bold>
, tested at the concentration of 10
<sup>−4</sup>
M, showed a growth of −27.31% against the SNB-75 cell line of the CNS cancer sub-panel and 4.73% against the HOP-92 of the non-small cell lung cancer sub-panel. The other tested compounds showed no significant activity.</p>
</sec>
<sec>
<title>3. Experimental</title>
<sec>
<title>3.1. Chemistry</title>
<sec sec-type="methods">
<title>3.1.1 General Procedures</title>
<p>All the commercially available reagents and solvents were used without further purification. 1,2-Diaza-1,3-diene (DD,
<bold>13</bold>
) was synthesized as a mixture of
<italic>E/Z</italic>
isomers as previously reported [
<xref rid="B27-molecules-18-02518" ref-type="bibr">27</xref>
,
<xref rid="B28-molecules-18-02518" ref-type="bibr">28</xref>
,
<xref rid="B29-molecules-18-02518" ref-type="bibr">29</xref>
]. Column chromatography was performed with Merck silica gel 230–400 mesh ASTM or with a Büchi Sepacor chromatography module (a prepacked cartridge system). TLC analysis was performed on pre-loaded (0.25 mm) glass-supported silica gel plates (Kieselgel 60); compounds were visualized by exposure to UV light and by dipping the plates in 1% Ce(SO
<sub>4</sub>
)·4H
<sub>2</sub>
O, 2.5% (NH
<sub>4</sub>
)
<sub>6</sub>
Mo
<sub>7</sub>
O
<sub>24</sub>
·4H
<sub>2</sub>
O in 10% sulfuric acid followed by heating on a hot plate.
<sup>1</sup>
H-NMR and
<sup>13</sup>
C-NMR spectra were recorded in DMSO-
<italic>d
<sub>6</sub>
</italic>
or CDCl
<sub>3</sub>
solution on 200 (Bruker AC) or 400 (Varian Mercury) MHz instruments. Proton and carbon spectra were referenced internally to solvent signals, using values of δ = 2.49 ppm for proton (middle peak) and δ = 39.50 ppm for carbon (middle peak) in DMSO-
<italic>d</italic>
<sub>6</sub>
and δ = 7.26 ppm for proton and δ = 77.00 ppm for carbon (middle peak) in CDCl
<sub>3</sub>
. The following abbreviations are used to describe peak patterns where appropriate: s = singlet, d = doublet, t = triplet q = quartet and m = multiplet. All coupling constants (
<italic>J</italic>
) are given in Hz. All melting points were taken on a Büchi-Tottoli capillary apparatus and are uncorrected; IR spectra were determined in bromoform or nujol with a Jasco FT/IR 5300 spectrophotometer. Mass spectra were recorded in the EI mode (70eV) on a Shimadzu GC-MS QP5050A spectrometer. Elemental analyses (C, H, N) were within ±0.4% of the theoretical values.</p>
<sec>
<title>3.1.1.1. General Procedure for the Preparation of 1,3-bis(indol-3-yl)propane-1,3-diones
<bold>12a</bold>
<bold>e</bold>
</title>
<p>A solution of malonyl dichloride (1 mL, 10 mmol) in DCM (10 mL) was added dropwise to a cold solution of the appropriate
<italic>N</italic>
-methylindole
<bold>11a</bold>
<bold>e</bold>
(20 mmol) in DCM (20 mL). The reaction mixture was stirred for 2 h at room temperature. The mixture was then added to 5% aqueous sodium carbonate and shaken for 2 min. This was extracted with DCM, dried and evaporated. The residue was purified by chromatography eluting with DCM/Ethyl acetate 9/1 to give derivatives
<bold>12a</bold>
<bold>e</bold>
. Analytical and spectroscopic data are reported elsewhere [
<xref rid="B12-molecules-18-02518" ref-type="bibr">12</xref>
].</p>
</sec>
<sec>
<title>3.1.1.2 General Procedure for the Preparation of Ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1H-indol-3-yl)-4-[(1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylates
<bold>10a</bold>
<bold>e</bold>
</title>
<p>To a solution of the appropriate 1,3-bis(indol-3-yl)propane-1,3-dione
<bold>12a</bold>
<bold>e</bold>
(1.0 mmol) in THF (5 mL), 1,2-diaza-1,3-diene (DD,
<bold>13</bold>
) as a mixture of E/Z isomers (1.0 mmol) and CuCl
<sub>2</sub>
∙2H
<sub>2</sub>
O (0.5 mmol) were added. The reaction was stirred under magnetic stirring at room temperature for 12 h, until the disappearance of the DD (as monitored by TLC). The crude mixture was concentrated under reduced pressure and the products
<bold>10a</bold>
<bold>e</bold>
were purified by column chromatography on silica gel (eluent: ethyl acetate/cyclohexane = 1:1).</p>
<p>
<italic>Ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1H-indol-3-yl)-4-[(1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylate</italic>
(
<bold>10a</bold>
). Pale yellow solid; yield: 98%; mp: 169–173 °C; IR (nujol) ν 3263, 1765, 1682, 1626 cm
<sup>−1</sup>
;
<sup>1</sup>
H-NMR (400 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 0.75 (t,
<italic>J</italic>
= 7.0 Hz, 3H), 1.34 (s, 9H), 2.39 (s, 3H), 3.68 (s, 3H), 3.69 (s, 3H), 3.87 (q,
<italic>J</italic>
= 7.0 Hz, 2H), 6.91 (t,
<italic>J</italic>
= 7.2 Hz, 1H), 7.08 (t,
<italic>J</italic>
= 7.2 Hz, 1H), 7.12 (t,
<italic>J</italic>
= 7.2 Hz, 1H), 7.17 (d,
<italic>J</italic>
= 7.2 Hz, 1H), 7.20 (s, 1H), 7.33 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 7.39 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 7.45 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 7.52 (s, 1H), 8.01 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 10.20 (s, 1H);
<sup>13</sup>
C-NMR (100 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 10.4 (q), 13.5 (q), 27.8 (q), 32.4 (q), 32.8 (q), 58.9 (t), 80.7 (s), 102.6 (s), 108.9 (s), 109.7 (d), 110.3 (d), 117.6 (s), 119.2 (s), 119.8 (d), 121.3 (2C, d), 121.6 (d), 122.5 (d), 122.8 (d), 125.9 (s), 127.6 (s), 130.6 (d), 135.8 (s), 136.1 (s), 137.1 (s), 137.6 (d), 154.6 (s), 163.8 (s), 186.5 (s). MS:
<italic>m/z</italic>
(%) = 554 [M
<sup>+</sup>
] (48), 498 (100), 454 (78), 392 (71), 367 (28), 338 (28), 158 (92). Anal. Calcd for C
<sub>32</sub>
H
<sub>34</sub>
N
<sub>4</sub>
O
<sub>5</sub>
: C, 69.30; H, 6.18; N, 10.10. Found: C, 69.47; H, 5.93; N, 10.22.</p>
<p>
<italic>Ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(1,5-dimethyl-1H-indol-3-yl)-4-[(1,5-dimethyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylate</italic>
(
<bold>10b</bold>
). Pale yellow solid; yield: 94%; mp: 186–190 °C; IR (nujol) ν 3247, 1744, 1684, 1628 cm
<sup>−1</sup>
;
<sup>1</sup>
H-NMR (400 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 0.79 (t,
<italic>J</italic>
= 7.0 Hz, 3H), 1.34 (s, 9H), 2.21 (s, 3H), 2.35 (s, 3H), 2.38 (s, 3H), 3.64 (s, 3H), 3.65 (s, 3H), 3.89 (q,
<italic>J</italic>
= 7.0 Hz, 2H), 6.88 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 6.99 (d,
<italic>J</italic>
= 7.2 Hz, 1H), 7.11 (s, 1H), 7.20 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 7.23 (s, 1H), 7.26 (d,
<italic>J</italic>
= 8.0 Hz, 1H), 7.49 (s, 1H), 7.81 (s, 1H), 10.16 (s, 1H);
<sup>13</sup>
C NMR (100 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 10.4 (q), 13.6 (q), 21.0 (q), 21.1 (q), 27.8 (q), 32.4 (q), 32.7 (q), 58.9 (t), 80.6 (s), 102.1 (s), 108.7 (s), 109.3 (d), 109.9 (d), 117.2 (s), 119.6 (d), 121.1 (d), 122.8 (d), 123,0 (s), 123.9 (d), 125.9 (s), 126.1 (s), 127.6 (s), 128.0 (s), 130.4 (d), 130.6 (s), 134.5 (s), 135.5 (s), 135.7 (s), 137.6 (d), 154.5 (s), 163.8 (s), 186.5 (s). MS:
<italic>m/z</italic>
(%) = 582 [M
<sup>+</sup>
] (45), 526 (100), 482 (98), 420 (53), 172 (68). Anal. Calcd for C
<sub>34</sub>
H
<sub>38</sub>
N
<sub>4</sub>
O
<sub>5</sub>
: C, 70.08; H, 6.57; N, 9.62. Found: C, 69.82; H, 6.75; N, 9.75.</p>
<p>
<italic>Ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(5-methoxy-1-methyl-1H-indol-3-yl)-4-[(5-methoxy-1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylate</italic>
(
<bold>10c</bold>
). White solid; yield: 83%; mp: 202–206 °C; IR (nujol) ν 3148, 1746, 1731, 1705 cm
<sup>−1</sup>
;
<sup>1</sup>
H-NMR (400 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 0.75 (t,
<italic>J</italic>
= 7.0 Hz, 3H), 1.35 (s, 9H), 2.39 (s, 3H), 3.32 (s, 6H), 3.68 (s, 3H), 3.71 (s, 3H), 3.88 (q,
<italic>J</italic>
= 7.0 Hz, 2H), 6.65 (d,
<italic>J</italic>
= 8.8 Hz, 1H), 6.78–6.83 (m, 2H), 7.14 (s, 1H), 7.22 (d,
<italic>J</italic>
= 8.8 Hz, 1H), 7.31 (d,
<italic>J</italic>
= 8.8 Hz, 1H), 7.47 (s, 1H), 7.60 (s, 1H), 10.15 (s, 1H);
<sup>13</sup>
C-NMR (100 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 10.4 (q), 13.5 (q), 27.8 (q), 32.6 (q), 32.9 (q), 54.5 (q), 55.1 (q), 58.9 (t), 80.7 (s), 101.2 (d), 102.3 (s), 102.8 (d), 108.9 (s), 110.4 (d), 111.2 (d), 111.7 (d), 112.4 (d), 117.5 (s), 122.7 (s), 126.0 (s), 126.7 (s), 128.0 (s), 130.4 (d), 131.2 (s), 132.2 (s), 135.7 (s), 137.5 (d), 153.6 (s), 154.6 (s), 155.4 (s), 163.8 (s), 186.5 (s). MS:
<italic>m/z</italic>
(%) = 614 [M
<sup>+</sup>
] (40), 558 (84), 514 (100), 499 (20), 452 (31), 188 (52). Anal. Calcd for C
<sub>34</sub>
H
<sub>38</sub>
N
<sub>4</sub>
O
<sub>7</sub>
: C, 66.43; H, 6.23; N, 9.11. Found: C, 66.79; H, 5.97; N, 9.23.</p>
<p>
<italic>Ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(5-chloro-1-methyl-1H-indol-3-yl)-4-[(5-chloro-1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylate</italic>
(
<bold>10d</bold>
). White solid; yield: 90%; mp: 195–199 °C; IR (nujol) ν 3257, 1754, 1678, 1637 cm
<sup>−1</sup>
;
<sup>1</sup>
H-NMR (400 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 0.76 (t,
<italic>J</italic>
= 7.2 Hz, 3H), 1.33 (s, 9H), 2.38 (s, 3H), 3.70 (s, 6H), 3.89 (q,
<italic>J</italic>
= 7.2 Hz, 2H), 7.08 (dd,
<italic>J</italic>
= 8.4 Hz,
<italic>J</italic>
= 1.8 Hz, 1H), 7.21 (dd,
<italic>J</italic>
= 8.4 Hz,
<italic>J</italic>
= 1.8 Hz, 1H), 7.29 (s, 1H), 7.38 (d, J = 8.4 Hz, 1H), 7.41–7.48 (m, 2H), 7.64 (s, 1H), 8.00 (d, J = 1.8 Hz, 1H), 10.26 (s, 1H);
<sup>13</sup>
C-NMR (100 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 10.3 (q), 13.5 (q), 27.7 (q), 32.7 (q), 33.0 (q), 59.0 (t), 80.8 (s), 102.2 (s), 108.8 (s), 111.4 (d), 112.2 (d), 117.0 (s), 119.0 (d), 120.3 (d), 121.3 (d), 122.6 (d), 122.8 (s), 124.3 (s), 125.4 (s), 126.6 (s), 126.8 (s), 128.6 (s), 132.4 (d), 134.6 (s), 135.7 (s), 136.2 (s), 138.9 (d), 154.5 (s), 163.6 (s), 186.3 (s). MS:
<italic>m/z</italic>
(%) = 622 [M
<sup>+</sup>
] (13), 566 (36), 522 (100), 507 (27), 357 (30), 328 (29), 192 (78). Anal. Calcd for C
<sub>32</sub>
H
<sub>32</sub>
Cl
<sub>2</sub>
N
<sub>4</sub>
O
<sub>5</sub>
: C, 61.64; H, 5.17; N, 8.99. Found: C, 61.77; H, 5.29; N, 8.91.</p>
<p>
<italic>Ethyl 1-[(tert-butoxycarbonyl)amino]-2-methyl-5-(5-bromo-1-methyl-1H-indol-3-yl)-4-[(5-bromo-1-methyl-1H-indol-3-yl)carbonyl]-1H-pyrrole-3-carboxylate</italic>
(
<bold>10e</bold>
). White solid; yield: 82%; mp: 201–205 °C; IR (nujol) ν 3261, 1755, 1693, 1637 cm
<sup>−1</sup>
;
<sup>1</sup>
H-NMR (400 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 0.77 (t,
<italic>J</italic>
= 7.0 Hz, 3H), 1.33 (s, 9H), 2.38 (s, 3H), 3.70 (s, 6H), 3.89 (q,
<italic>J</italic>
= 7.0 Hz, 2H), 7.19 (d,
<italic>J</italic>
= 8.4 Hz, 1H), 7.27 (s, 1H), 7.31–7.36 (m, 2H), 7.41 (d, J = 8.4 Hz, 1H), 7.56 (s, 1H), 7.63 (s, 1H), 8.17 (s, 1H), 10.26 (s, 1H);
<sup>13</sup>
C-NMR (100 MHz, DMSO-
<italic>d
<sub>6</sub>
</italic>
) δ 10.3 (q), 13.6 (q), 27.8 (q), 32.6 (q), 33.0 (q), 59.0 (t), 80.8 (s), 102.1 (s), 108.8 (s), 111.9 (s), 112.3 (s), 112.6 (d), 114.7 (d), 116.9 (s), 122.0 (d), 122.8 (s), 123.3 (d), 123.8 (d), 125.1 (d), 125.4 (s), 127.4 (s), 129.2 (s), 132.3 (d), 134.8 (s), 135.9 (s), 136.1 (s), 138.8 (d), 154.5 (s), 163.6 (s), 186.3 (s). MS:
<italic>m/z</italic>
(%) = 710 [M
<sup>+</sup>
] (26), 612 (100), 566 (20), 471 (23), 401 (25), 252 (60), 236 (35), 181 (35). Anal. Calcd for C
<sub>32</sub>
H
<sub>32</sub>
Br
<sub>2</sub>
N
<sub>4</sub>
O
<sub>5</sub>
: C, 53.95; H, 4.53; N, 7.86. Found: C, 53.76; H, 4.65; N, 8.01.</p>
</sec>
</sec>
</sec>
<sec>
<title>3.2. Biology</title>
<sec sec-type="methods">
<title>3.2.1. Methodology of the
<italic>in Vitro</italic>
Cancer Screen</title>
<p>The human tumor cell lines of the cancer screening panel are grown in RPMI 1640 medium containing 5% fetal bovine serum and 2 mM L-glutamine. For a typical screening experiment, cells are inoculated into 96 well microtiter plates in 100 µL at plating densities ranging from 5,000 to 40,000 cells/well depending on the doubling time of individual cell lines. After cell inoculation, the microtiter plates are incubated at 37 °C, 5% CO
<sub>2</sub>
, 95% air and 100% relative humidity for 24 h prior to addition of experimental drugs. After 24 h, two plates of each cell line are fixed
<italic>in situ</italic>
with TCA, to represent a measurement of the cell population for each cell line at the time of drug addition (Tz). Experimental drugs are solubilized in dimethyl sulfoxide at 400-fold the desired final maximum test concentration and stored frozen prior to use. At the time of drug addition, an aliquot of frozen concentrate is thawed and diluted to twice the desired final maximum test concentration with complete medium containing 50 µg/mL gentamicin. Additional four, 10-fold or ½ log serial dilutions are made to provide a total of five drug concentrations plus control. Aliquots of 100 µL of these different drug dilutions are added to the appropriate microtiter wells already containing 100 µL of medium, resulting in the required final drug concentrations. Following drug addition, the plates are incubated for an additional 48 h at 37 °C, 5% CO
<sub>2</sub>
, 95% air, and 100% relative humidity. For adherent cells, the assay is terminated by the addition of cold TCA. Cells are fixed
<italic>in situ</italic>
by the gentle addition of 50 µL of cold 50% (w/v) TCA (final concentration, 10% TCA) and incubated for 60 min at 4 °C. The supernatant is discarded, and the plates are washed five times with tap water and air dried. Sulforhodamine B (SRB) solution (100 µL) at 0.4% (w/v) in 1% acetic acid is added to each well, and plates are incubated for 10 min at room temperature. After staining, unbound dye is removed by washing five times with 1% acetic acid and the plates are air dried. Bound stain is subsequently solubilized with 10 mM trizma base, and the absorbance is read on an automated plate reader at a wavelength of 515 nm. For suspension cells, the methodology is the same except that the assay is terminated by fixing settled cells at the bottom of the wells by gently adding 50 µL of 80% TCA (final concentration, 16% TCA). Using the seven absorbance measurements [time zero, (Tz), control growth, (C), and test growth in the presence of drug at the five concentration levels (Ti)], the percentage growth is calculated at each of the drug concentrations levels. Percentage growth inhibition is calculated as:
<disp-formula>[(Ti-Tz)/(C-Tz)] × 100 for concentrations for which Ti>/=Tz</disp-formula>
<disp-formula>[(Ti-Tz)/Tz] × 100 for concentrations for which Ti</disp-formula>
</p>
<p>For further information to see NCI website [
<xref rid="B30-molecules-18-02518" ref-type="bibr">30</xref>
].</p>
</sec>
</sec>
</sec>
<sec>
<title>4. Conclusions</title>
<p>In conclusion, five ethyl 1-[(
<italic>tert</italic>
-butoxycarbonyl)amino]-2-methyl-5-(1-methyl-1
<italic>H</italic>
-indol-3-yl)-4-[(1-methyl-1
<italic>H</italic>
-indol-3-yl)carbonyl]-1
<italic>H</italic>
-pyrrole-3-carboxylates derivatives
<bold>10a</bold>
<bold>e</bold>
, analogues of the marine alkaloid topsentin, in which the imidazole moiety was replaced by a pyrrole ring, were obtained. Only one of these compounds (compound
<bold>10e</bold>
) showed moderate activity against two cell lines belonging to the NCI CNS and non-small cell lung cancer sub-panels.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This work was financially supported by Ministero dell’Istruzione dell'Università e della Ricerca. We thank the National Cancer Institute (Bethesda, MD, USA) for the antitumor tests.</p>
</ack>
<fn-group>
<fn>
<p>
<italic>Sample Availability</italic>
: Samples of the compounds
<bold>10a</bold>
<bold>e</bold>
are available from the authors. </p>
</fn>
</fn-group>
<ref-list>
<title>References and Notes</title>
<ref id="B1-molecules-18-02518">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>K.W.</given-names>
</name>
<name>
<surname>Rho</surname>
<given-names>J.R.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>New Bis(indole)Alkaloids of the Topsentin class from the sponge Spongosorites genitrix</article-title>
<source>J. Nat. Prod.</source>
<year>1999</year>
<volume>62</volume>
<fpage>647</fpage>
<lpage>649</lpage>
<pub-id pub-id-type="doi">10.1021/np980507b</pub-id>
<pub-id pub-id-type="pmid">10217734</pub-id>
</element-citation>
</ref>
<ref id="B2-molecules-18-02518">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casapullo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bifulco</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Riccio</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Hamacanthin Classes from the Mediterranean Marine Sponge Raphisia lacazei</article-title>
<source>J. Nat. Prod.</source>
<year>2000</year>
<volume>63</volume>
<fpage>447</fpage>
<lpage>451</lpage>
<pub-id pub-id-type="doi">10.1021/np9903292</pub-id>
<pub-id pub-id-type="pmid">10785411</pub-id>
</element-citation>
</ref>
<ref id="B3-molecules-18-02518">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hong</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>C.J.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>J.H.</given-names>
</name>
</person-group>
<article-title>Cytotoxic Bisindole Alkaloids from a Marine Sponge Spongosorites sp.</article-title>
<source>J. Nat. Prod.</source>
<year>2005</year>
<volume>68</volume>
<fpage>711</fpage>
<lpage>715</lpage>
<pub-id pub-id-type="doi">10.1021/np049577a</pub-id>
<pub-id pub-id-type="pmid">15921415</pub-id>
</element-citation>
</ref>
<ref id="B4-molecules-18-02518">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gul</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hamann</surname>
<given-names>M.T.</given-names>
</name>
</person-group>
<article-title>Indole alkaloid marine natural products: An established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases</article-title>
<source>Life Sci.</source>
<year>2005</year>
<volume>78</volume>
<fpage>442</fpage>
<lpage>453</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2005.09.007</pub-id>
<pub-id pub-id-type="pmid">16236327</pub-id>
</element-citation>
</ref>
<ref id="B5-molecules-18-02518">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kohmoto</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kashman</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>McConnell</surname>
<given-names>O.J.</given-names>
</name>
<name>
<surname>Rinehart</surname>
<given-names>K.L.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Wright</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Koehn</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>The first total synthesis of Dragmacidin D</article-title>
<source>J. Org. Chem.</source>
<year>1988</year>
<volume>53</volume>
<fpage>3116</fpage>
<lpage>3118</lpage>
</element-citation>
</ref>
<ref id="B6-molecules-18-02518">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Andersen</surname>
<given-names>R.J.</given-names>
</name>
</person-group>
<article-title>Brominated bis(indole)alkaloids from the marine sponge Hexadella sp.</article-title>
<source>Tetrahedron</source>
<year>1990</year>
<volume>46</volume>
<fpage>715</fpage>
<lpage>720</lpage>
<pub-id pub-id-type="doi">10.1016/S0040-4020(01)81355-7</pub-id>
</element-citation>
</ref>
<ref id="B7-molecules-18-02518">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fahy</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Potts</surname>
<given-names>B.C.M.</given-names>
</name>
<name>
<surname>Faulkner</surname>
<given-names>D.J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>6-Bromotryptamine Derivatives from the Gulf of California Tunicate Didemnum candidum</article-title>
<source>J. Nat. Prod.</source>
<year>1991</year>
<volume>54</volume>
<fpage>564</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="doi">10.1021/np50074a032</pub-id>
</element-citation>
</ref>
<ref id="B8-molecules-18-02518">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wright</surname>
<given-names>A.E.</given-names>
</name>
<name>
<surname>Pomponi</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>A new bis-(indole)alkaloids from a deep-water marine sponge of the genus Spongosorites</article-title>
<source>J. Org. Chem.</source>
<year>1992</year>
<volume>57</volume>
<fpage>4772</fpage>
<lpage>4775</lpage>
<pub-id pub-id-type="doi">10.1021/jo00043a045</pub-id>
</element-citation>
</ref>
<ref id="B9-molecules-18-02518">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capon</surname>
<given-names>R.J.</given-names>
</name>
<name>
<surname>Rooney</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>L.M.</given-names>
</name>
<name>
<surname>Collins</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sim</surname>
<given-names>A.T.R.</given-names>
</name>
<name>
<surname>Rostas</surname>
<given-names>J.A.P.</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>A.R.</given-names>
</name>
</person-group>
<article-title>Dragmacidins: New protein phosphatase inhibitors from a Southern Australian deep-water Marine Sponge
<italic>Spongosorites</italic>
sp.</article-title>
<source>J. Nat. Prod.</source>
<year>1998</year>
<volume>61</volume>
<fpage>660</fpage>
<lpage>662</lpage>
<pub-id pub-id-type="doi">10.1021/np970483t</pub-id>
<pub-id pub-id-type="pmid">9599272</pub-id>
</element-citation>
</ref>
<ref id="B10-molecules-18-02518">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alvarez</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Salas</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Marine, nitrogen-containing heterocyclic natural products-structures and syntheses of compounds containing indole units</article-title>
<source>Heterocycles</source>
<year>1991</year>
<volume>32</volume>
<fpage>1391</fpage>
<lpage>1429</lpage>
<pub-id pub-id-type="doi">10.3987/REV-91-429</pub-id>
</element-citation>
</ref>
<ref id="B11-molecules-18-02518">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakem</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>H.H.</given-names>
</name>
</person-group>
<article-title>Cytotoxic and antifungal imidazolediylbis[indoles] from the sponge Spongosorites ruetzleri</article-title>
<source>J. Org. Chem.</source>
<year>1991</year>
<volume>56</volume>
<fpage>4304</fpage>
<lpage>4307</lpage>
<pub-id pub-id-type="doi">10.1021/jo00013a044</pub-id>
</element-citation>
</ref>
<ref id="B12-molecules-18-02518">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartik</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Braekman</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>Daloze</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stoller</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Topsentin, new toxic bis-indole alkaloids from the marine sponge Topsentia genitrix</article-title>
<source>Can. J. Chem.</source>
<year>1987</year>
<volume>65</volume>
<fpage>2118</fpage>
<lpage>2121</lpage>
<pub-id pub-id-type="doi">10.1139/v87-352</pub-id>
</element-citation>
</ref>
<ref id="B13-molecules-18-02518">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Burres</surname>
<given-names>N.S.</given-names>
</name>
<name>
<surname>Barber</surname>
<given-names>D.A.</given-names>
</name>
<name>
<surname>Gunasekera</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>L.L.</given-names>
</name>
<name>
<surname>Clement</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Antitumor activity and biochemical effects of topsentin</article-title>
<source>Biochem. Pharmacol.</source>
<year>1991</year>
<volume>42</volume>
<fpage>745</fpage>
<lpage>751</lpage>
<pub-id pub-id-type="pmid">1867631</pub-id>
</element-citation>
</ref>
<ref id="B14-molecules-18-02518">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsuji</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rinehart</surname>
<given-names>K.L.</given-names>
</name>
<name>
<surname>Gunasekera</surname>
<given-names>S.P.</given-names>
</name>
<name>
<surname>Kashman</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>S.S.</given-names>
</name>
<name>
<surname>Lui</surname>
<given-names>M.S.</given-names>
</name>
<name>
<surname>Pomponi</surname>
<given-names>S.A.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>M.C.</given-names>
</name>
</person-group>
<article-title>Topsentin, Bromotopsentin, and Dihydrodeoxybromotopsentin: Antiviral and Antitumor bis (indolyl)imidazoles from Caribbean deep-sea sponge of the family Halichondriidae. Structural and synthetic studies</article-title>
<source>J. Org. Chem.</source>
<year>1988</year>
<volume>53</volume>
<fpage>5446</fpage>
<lpage>5453</lpage>
</element-citation>
</ref>
<ref id="B15-molecules-18-02518">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Syntheses and biological activities of bis(3-indolyl)thiazoles, analogues of marine bis(indole)alkaloid nortopsentin</article-title>
<source>Bioorg. Med. Chem. Lett.</source>
<year>1999</year>
<volume>9</volume>
<fpage>569</fpage>
<lpage>572</lpage>
<pub-id pub-id-type="doi">10.1016/S0960-894X(99)00037-2</pub-id>
<pub-id pub-id-type="pmid">10098665</pub-id>
</element-citation>
</ref>
<ref id="B16-molecules-18-02518">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>X.H.</given-names>
</name>
</person-group>
<article-title>Syntheses and cytotoxicity evaluation of bis(indolyl)thiazole, bis(indolyl)pyrazinone and bis(indolyl)pyrazine: analogues of cytotoxic marine bis(indole) alkaloid</article-title>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2000</year>
<volume>8</volume>
<fpage>363</fpage>
<lpage>371</lpage>
<pub-id pub-id-type="doi">10.1016/S0968-0896(99)00290-4</pub-id>
</element-citation>
</ref>
<ref id="B17-molecules-18-02518">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Synthesis and cytotoxicity evaluation of novel indolylpyrimidines and indolylpyrazines as potential antitumor agents</article-title>
<source>Bioorg. Med. Chem.</source>
<year>2001</year>
<volume>9</volume>
<fpage>1149</fpage>
<lpage>1154</lpage>
<pub-id pub-id-type="doi">10.1016/S0968-0896(00)00337-0</pub-id>
<pub-id pub-id-type="pmid">11377173</pub-id>
</element-citation>
</ref>
<ref id="B18-molecules-18-02518">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Synthesis and antitumor evaluation of novel monoindolyl-4-trifluoromethylpyridines and bisindolyl-4-trifluoromethylpyridines</article-title>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2001</year>
<volume>11</volume>
<fpage>475</fpage>
<lpage>477</lpage>
<pub-id pub-id-type="doi">10.1016/S0960-894X(00)00704-6</pub-id>
<pub-id pub-id-type="pmid">11229751</pub-id>
</element-citation>
</ref>
<ref id="B19-molecules-18-02518">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Synthesis of novel analogues of marine indole alkaloids: mono(indolyl)-4-trifluoromethylpyridines and bis(indolyl)-4-trifluoromethylpyridines as potential anticancer agents</article-title>
<source>Bioorg. Med. Chem.</source>
<year>2001</year>
<volume>9</volume>
<fpage>1773</fpage>
<lpage>1770</lpage>
<pub-id pub-id-type="doi">10.1016/S0968-0896(01)00070-0</pub-id>
<pub-id pub-id-type="pmid">11425579</pub-id>
</element-citation>
</ref>
<ref id="B20-molecules-18-02518">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diana</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carbone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barraja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Montalbano</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martorana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dattolo</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Gia</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dalla Via</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cirrincione</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Synthesis and antitumor properties of 2,5-bis(3’-indolyl)thiophenes: analogues of marine alkaloid nortopsentin</article-title>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2007</year>
<volume>17</volume>
<fpage>2342</fpage>
<lpage>2346</lpage>
<pub-id pub-id-type="pmid">17306531</pub-id>
</element-citation>
</ref>
<ref id="B21-molecules-18-02518">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diana</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carbone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barraja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Martorana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gia</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Dalla Via</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cirrincione</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>3,5-Bis(3’-indolyl)pyrazoles, analogues of marine alkaloid nortopsentin: synthesis and antitumor properties</article-title>
<source>Bioorg. Med. Chem. Lett.</source>
<year>2007</year>
<volume>17</volume>
<fpage>6134</fpage>
<lpage>6137</lpage>
<pub-id pub-id-type="doi">10.1016/j.bmcl.2007.09.042</pub-id>
<pub-id pub-id-type="pmid">17911018</pub-id>
</element-citation>
</ref>
<ref id="B22-molecules-18-02518">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Diana</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Carbone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Barraja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kelter</surname>
<given-names>H.H.</given-names>
</name>
<name>
<surname>Fiebig</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cirrincione</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Synthesis and antitumor activity of 2,5-bis(3’-indolyl)-furans and 3,5-bis(3’-indolyl)-isoxazoles, nortopsentin analogues</article-title>
<source>Bioorg. Med. Chem.</source>
<year>2010</year>
<volume>18</volume>
<fpage>4524</fpage>
<lpage>4529</lpage>
<pub-id pub-id-type="doi">10.1016/j.bmc.2010.04.061</pub-id>
<pub-id pub-id-type="pmid">20472437</pub-id>
</element-citation>
</ref>
<ref id="B23-molecules-18-02518">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carbone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Parrino</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Barraja</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Spanò</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Cirrincione</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Diana</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kelter</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fiebig</surname>
<given-names>H-H.</given-names>
</name>
</person-group>
<article-title>Synthesis and antiproliferative activity of 2,5-bis(3’-Indolyl)pyrroles, analogues of the marine alkaloid Nortopsentin</article-title>
<source>Marine Drugs</source>
<year>2013</year>
<volume>11</volume>
<pub-id pub-id-type="doi">10.3390/md110x000x</pub-id>
</element-citation>
</ref>
<ref id="B24-molecules-18-02518">
<label>24.</label>
<note>
<p>Recent review on the chemistry of 1,2-diaza-1,3-dienes, see:</p>
</note>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attanasi</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>De Crescentini</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Favi</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Filippone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mantellini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Perrulli</surname>
<given-names>F.R.</given-names>
</name>
<name>
<surname>Santeusanio</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cultivating the passion to build heterocycles from 1,2-diaza-1,3-dienes: the Force of immagination</article-title>
<source>Eur. J. Org. Chem.</source>
<year>2009</year>
<fpage>3109</fpage>
<lpage>3127</lpage>
</element-citation>
</ref>
<ref id="B25-molecules-18-02518">
<label>25.</label>
<note>
<p>Report on copper-catalyzed synthesis of pyrroles from 1,2-diaza-1,3-dienes, see: (b)</p>
</note>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attanasi</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Grossi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Serra-Zanetti</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Foresti</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Effect of metal ions in organic synthesis. Part XXXIII. 2-hydroxy-4-pyrrolines as stable intermediates in the synthesis of 1-aminopyrrole derivatives</article-title>
<source>Tetrahedron</source>
<year>1987</year>
<volume>43</volume>
<fpage>4249</fpage>
<lpage>4256</lpage>
</element-citation>
</ref>
<ref id="B26-molecules-18-02518">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Monks</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Scudiero</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Skehan</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Shoemaker</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Paull</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Vistica</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hose</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Langely</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cronise</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Vaigro-Wolff</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Feasibility of a high-flux anticancer drug screen using a diverse panel of culture human tumor cell lines</article-title>
<source>J. Natl. Cancer Inst.</source>
<year>1991</year>
<volume>83</volume>
<fpage>757</fpage>
<lpage>766</lpage>
<pub-id pub-id-type="doi">10.1093/jnci/83.11.757</pub-id>
<pub-id pub-id-type="pmid">2041050</pub-id>
</element-citation>
</ref>
<ref id="B27-molecules-18-02518">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sommer</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Inverse diels-alder-reaktionen von azo-alkenen mit aliene</article-title>
<source>Tetrahedron Lett.</source>
<year>1977</year>
<volume>18</volume>
<fpage>117</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1016/S0040-4039(01)92565-1</pub-id>
</element-citation>
</ref>
<ref id="B28-molecules-18-02518">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attanasi</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Filippone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santeusanio</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Effect of metal ions in organic synthesis; Part XXIII. Easy and high-yield direct synthesis of 3-aminocarbonyl-1-ureidopyrroles by the copper(II) chloride-catalyzed reaction of aminocarbonylazoalkenes with 3-oxoalkanamides</article-title>
<source>Synthesis</source>
<year>1984</year>
<fpage>671</fpage>
<lpage>672</lpage>
</element-citation>
</ref>
<ref id="B29-molecules-18-02518">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attanasi</surname>
<given-names>O.A.</given-names>
</name>
<name>
<surname>Filippone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Mei</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Santeusanio</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Effect of metal ions in organic. Synthesis; Part XXIV. Facile one-flask synthesis of 1-alkoxycarbonylamino by reaction of alkoxycarbonylamino-3-aminocarbonylpyrroles by reaction of alkoxycarbonylazoalkenes with 3-oxoalkanamides under copper(II) chloride catalysis</article-title>
<source>Synthesis</source>
<year>1984</year>
<fpage>873</fpage>
<lpage>874</lpage>
</element-citation>
</ref>
<ref id="B30-molecules-18-02518">
<label>30.</label>
<element-citation publication-type="webpage">
<article-title>NCI-60 DTP Human tumor cell line screen</article-title>
<comment>Available online:
<ext-link ext-link-type="uri" xlink:href="http://dtp.nci.nih.gov/branches/btb/ivclsp.html">http://dtp.nci.nih.gov/branches/btb/ivclsp.html</ext-link>
</comment>
<date-in-citation>(accessed on 12 March 2012)</date-in-citation>
</element-citation>
</ref>
</ref-list>
</back>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000960 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000960 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:6269752
   |texte=   A Facile Synthesis of Deaza-Analogues of the Bisindole Marine Alkaloid Topsentin
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:23442928" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV2 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021